Key clinical point: Blood transfusion is unlikely to be a RA transmission route.
Major finding: Recipients had similar risk of RA whether or not the donor later developed RA.
Data source: Retrospective analysis of 938,942 blood donors and 152,839 recipients.
Disclosures: The study was funded by the Danish Rheumatism Association, the Odense University Hospital PhD Fund and Fund for clinical research, the Nordic Cancer Union, the Swedish Foundation for Strategic Research, the Swedish Research Council, and ALF funds. One author reported receiving grants from AbbVie, Bristol-Myers Squibb, Merck, Pfizer, Roche, Samsung, and UCB.
Source: Just SA et al. Ann Rheum Dis. 2018 Mar 1. doi: 10.1136/annrheumdis-2017-212844.
Just SA et al. Ann Rheum Dis. 2018 Mar 1. doi: 10.1136/annrheumdis-2017-212844.
This Week's Must Reads
LVADs as destination therapy, Mehra MR et al. New Engl J Med DOI: 10.1056/NEJMoa1800866.
Treatment-free remission in CML, Mahon FX et al. Ann Intern Med. 2018 Feb 20. doi: 10.7326/M17-1094.
Anticoagulation linked to low BMD in children, Patel KN et al. Thrombosis & Hemostasis Societies of North America 2018, Poster 65.
New option for chronic graft vs. host, Lazaryan A et al. 2018 BMT Tandem Meetings, Abstract 38.
In myeloma, go for a third transplant, Garderet L et al. Biol Blood Marrow Transplant. 2018 Feb 3. doi: 10.1016/j.bbmt.2018.01.035
Must Reads in Transfusion Medicine
Transfusions don't factor in rheumatoid arthritis transmission, Just SA et al. Ann Rheum Dis. 2018 Mar 1. doi: 10.1136/annrheumdis-2017-212844.
Cochrane Evaluates Red Blood Cell Transfusion Policies, Cochrane Database Syst Rev; 2017 Jan 27; Estcourt, et al
Comparison of Red Blood Cell Transfusion Utilization, J Thromb Haemost; ePub 2016 Oct 28; Belk, et al
CMV Reactivation in Allogeneic HCT, Does it have a protective effect?